Prognostic value of high-field proton magnetic resonance spectroscopy in patients presenting with clinically isolated syndromes suggestive of multiple sclerosis

Neuroradiology

Volumn 50, Issue 2, 2008, Pages 123-129

  Wattjes, Mike P ^a,b   Harzheim, Michael ^a   Lutterbey, Götz G ^a   Bogdanow, Manuela ^a   Schmidt, Stephan ^a   Schild, Hans H ^a   Träber, Frank ^a  

^a UNIVERSITY OF BONN   (Germany)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

Author keywords

Clinically isolated syndromes; MRS; Multiple sclerosis; NAWM

Indexed keywords

CHOLINE; CREATINE; INOSITOL; N ACETYLASPARTIC ACID;

ADULT; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MALE; MULTIPLE SCLEROSIS; NEUROIMAGING; NUCLEAR MAGNETIC RESONANCE IMAGING; PRIORITY JOURNAL; PROTON NUCLEAR MAGNETIC RESONANCE; WHITE MATTER;

ADOLESCENT; ADULT; FEMALE; HUMANS; MAGNETIC RESONANCE SPECTROSCOPY; MALE; MIDDLE AGED; MULTIPLE SCLEROSIS; PROGNOSIS; PROTONS; SYNDROME;

EID: 38649093042     PISSN: 00283940     EISSN: None     Source Type: Journal    
DOI: 10.1007/s00234-007-0325-y     Document Type: Article

References (38)

1. Rovira Canellas A, Rovira Gols A, Rio Izquierdo J, Tintoré Subirana M, Montalban Gairin X (2007) Idiopathic inflammatory-demyelinating diseases of the central nervous system. Neuroradiology 49:393-409
2. Miller DH, Thompson AJ, Filippi M (2003) Magnetic resonance studies of abnormalities in the normal appearing white matter and grey matter in multiple sclerosis. J Neurol 250:1407-1419
3. Brex PA, Ciccarelli O, O' Riordan JI, Sailer M, Thompson AJ, Miller DH (2002) A longitudinal study of abnormalities on MRI and disability from multiple sclerosis. N Engl J Med 346:158-164
4. Barkhof F, Filippi M, Miller DH et al (1997) Comparison of MRI criteria at first presentation to predict conversion to clinically definite multiple sclerosis. Brain 120:2059-2069
5. Tintoré M, Rovira A, Martinez MJ et al (2000) Isolated demyelinating syndromes: comparison of different MR imaging criteria to predict conversion to clinically definite multiple sclerosis. AJNR Am J Neuroradiol 21:702-706
6. Minneboo A, Barkhof F, Polman CH et al (2004) Infratentorial lesions predict long-term disability in patients with initial findings suggestive of multiple sclerosis. Arch Neurol 61:217-221
7. Bitsch A, Bruhn H, Vougioukas V et al (1999) Inflammatory CNS demyelination: histopathologic correlation with in vivo quantitative proton MR spectroscopy. AJNR Am J Neuroradiol 20:1619-1627
8. Simmons ML, Frodonza CG, Coyle JT (1991) Immunocytochemical localization of N-acetyl-aspartate with monoclonal antibodies. Neuroscience 45:37-45
9. Nakano M, Ueda H, Li J et al (1998) Measurement of regional N-acetylaspartate after transient global ischemia in gerbils with and without ischemic tolerance: an index of neuronal survival. Ann Neurol 44:334-340
10. Brand A, Richter-Landsberg C, Leibfritz D (1993) Multinuclear NMR studies on the energy metabolism of glial and neuronal cells. Dev Neurosci 15:289-298
11. De Stefano N, Narayanan S, Francis GS et al (2001) Evidence of axonal damage in the early stages of multiple sclerosis and its relevance to disability. Arch Neurol 58:65-70
12. De Stefano N, Matthews PM, Fu L et al (1998) Axonal damage correlates with disability in patients with relapsing-remitting multiple sclerosis. Results of a longitudinal magnetic resonance spectroscopy study. Brain 121:1469-1477
13. Chard DT, Griffin CM, McLean MA et al (2002) Brain metabolite changes in cortical grey and normal-appearing white matter in clinically early relapsing remitting multiple sclerosis. Brain 125:2342-2352
14. Kapeller P, McLean MA, Griffin CM et al (2001) Preliminary evidence for neuronal damage in cortical grey and normal appearing white matter in short duration relapsing-remitting multiple sclerosis: a quantitative MR spectroscopic imaging study. J Neurol 248:131-138
15. Vrenken H, Barkhof F, Uitdehaag BMJ, Castelijns JA, Polman CH, Pouwels PJW (2005) MR spectroscopic evidence of glial increase but not for neuro-axonal damage in MS normal-appearing white matter. Magn Reson Med 53:256-266
16. Srinivasan R, Sailasuta N, Hurd R, Nelson S, Pelletier D (2005) Evidence of elevated glutamate in multiple sclerosis using magnetic resonance spectroscopy at 3T. Brain 128:1016-1025
17. Tedeschi G, Bonavita S, McFarland HF, Richert N, Duyn JH, Frank JA (2002) Proton MR spectroscopic imaging in multiple sclerosis. Neuroradiology 44:37-42
18. Fernando KTM, McLean MA, Chard DT et al (2004) Elevated white matter myo-inositol in clinical isolated syndromes suggestive of multiple sclerosis. Brain 127:1361-1369
19. Polman CH, Reingold SC, Edan G et al (2005) Diagnostic criteria for multiple sclerosis: 2005 revisions to the "McDonald Criteria". Ann Neurol 58:840-846
20. Kurtzke JF (1983) Rating neurologic impairment in multiple sclerosis: an expanded disability status scale (EDSS). Neurology 33:1444-1452
21. Wattjes MP, Lutterbey GG, Harzheim M et al (2006) Imaging of inflammatory lesions at 3.0 Tesla in patients with clinically isolated syndromes suggestive of multiple sclerosis: a comparison of fluid-attenuated inversion recovery with T2 turbo spin-echo. Eur Radiol 16:1494-1500
22. Simon JH, Li D, Traboulsee A et al (2006) Standardized MR imaging protocol for multiple sclerosis: consortium of MS centers consensus guidelines. AJNR Am J Neuroradiol 27:455-461
23. Naressi A, Couturier C, Devos JM et al (2001) Java-based graphical user interface for the MRUI quantitation package. MAGMA 12:141-152
24. Vanhamme L, van den Boogaart A, van Huffel S (1997) Improved method for accurate and efficient quantification of MRS data with use of prior knowledge. J Magn Reson 129:35-43
25. Wattjes MP, Harzheim M, Lutterbey GG, Klotz L, Schild HH, Träber F (2007) Axonal damage but no increased glial cell activity in the normal-appearing white matter of patients with clinically isolated syndromes suggestive of multiple sclerosis using high field magnetic resonance spectroscopy. AJNR Am J Neuroradiol 28:1517-1522
26. Fernando KTM, Tozer DJ, Mizkiel KA et al (2005) Magnetization transfer histograms in clinically isolated syndromes suggestive of multiple sclerosis. Brain 128:2911-2925
27. Vrenken H, Rombouts SARB, Pouwels PJW, Barkhof F (2006) Voxel -based analysis of quantitative T1 maps demonstrates that multiple sclerosis acts throughout the normal-appearing white matter. AJNR Am J Neuroradiol 27:868-874
28. Vrenken H, Pouwels PJW, Geurts JJG et al (2006) Altered diffusion tensor in multiple sclerosis normal-appearing brain tissue: cortical diffusion seem related to clinical deterioration. J Magn Reson Imaging 23:628-636
29. Nielsen JM, Korteweg T, Barkhof F, Uitdehaag BMJ, Polman CH (2005) Overdiagnosis of multiple sclerosis and magnetic resonance imaging criteria. Ann Neurol 58:781-783
30. Wattjes MP, Lutterbey GG, Harzheim M et al (2006) Higher sensitivity in the detection of inflammatory brain lesions in patients with clinically isolated syndromes suggestive of multiple sclerosis using high field MRI: an intraindividual comparison of 1.5T with 3.0T. Eur Radiol 16:2067-2073
31. Keiper MD, Grossmann RI, Hirsch JA et al (1998) MR identification of white matter abnormalities in multiple sclerosis: a comparison between 1.5T and 4T. AJNR Am J Neuroradiol 19:1489-1493
32. Wattjes MP, Harzheim M, Kuhl CK et al (2006) Does high-field MRI have an influence on the classification of patients with clinically isolated syndromes according to current diagnostic magnetic resonance imaging criteria for multiple sclerosis? AJNR Am J Neuroradiol 27:1794-1798
33. Träber F, Block W, Lamerichs R, Gieseke J, Schild HH (2004) 1H metabolite relaxation times at 3.0 Tesla: measurements of T1 and T2 values in normal brain and determination of regional differences in transverse relaxation. J Magn Reson Imaging 19:537-545
34. Srinivasan R, Vigneron D, Sailasuta N, Hurd R, Nelson S (2004) A comparative study of myoinositol quantification using LCmodel at 1.5 T and 3.0 T with 3 D 1H proton spectroscopic imaging of the human brain. Magn Reson Imaging 22:523-528
35. Tourbah A, Stievenart JL, Abanou A et al (1999) Normal-appearing white matter in optic neuritis and multiple sclerosis: a comparative proton spectroscopy study. Neuroradiology 41:738-743
36. Fernando KTM, Chard DT, McLean MA et al (2006) Metabolite changes in the white matter 3 years after a clinically isolated syndrome suggestive of multiple sclerosis. Mult Scler 12(S1):41
37. Pit D, Werner P, Raine C (2000) Glutamate excitotoxicity in a model of multiple sclerosis. Nat Med 6:67-70
38. Cianfoni A, Niku S, Imbesi SG (2007) Metabolite findings in tumefactive demyelinating lesions utilizing short echo time proton magnetic resonance spectroscopy. AJNR Am J Neuroradiol 28:272-277